Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 1,330 shares of Arteris stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $8.38, for a total value of $11,145.40. Following the completion of the sale, the chief executive officer now directly owns 327,240 shares in the company, valued at approximately $2,742,271.20. This represents a 0.40 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
K Charles Janac also recently made the following trade(s):
- On Monday, February 3rd, K Charles Janac sold 50,000 shares of Arteris stock. The shares were sold at an average price of $10.33, for a total value of $516,500.00.
- On Monday, January 6th, K Charles Janac sold 8,432 shares of Arteris stock. The shares were sold at an average price of $12.34, for a total value of $104,050.88.
- On Thursday, January 2nd, K Charles Janac sold 6,256 shares of Arteris stock. The stock was sold at an average price of $11.41, for a total value of $71,380.96.
- On Monday, December 30th, K Charles Janac sold 58,212 shares of Arteris stock. The stock was sold at an average price of $10.33, for a total value of $601,329.96.
- On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The stock was sold at an average price of $10.42, for a total value of $631,285.28.
- On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $141,941.80.
- On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total value of $180,702.72.
Arteris Trading Up 2.6 %
Shares of NASDAQ:AIP opened at $8.41 on Thursday. Arteris, Inc. has a 12-month low of $5.76 and a 12-month high of $12.64. The stock has a market cap of $344.37 million, a PE ratio of -9.67 and a beta of 1.18. The business has a 50 day moving average of $10.39 and a 200-day moving average of $8.83. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.30.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on AIP. Northland Securities boosted their price target on Arteris from $14.00 to $16.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 19th. Rosenblatt Securities reissued a “buy” rating and set a $15.00 price target on shares of Arteris in a research report on Tuesday, February 18th.
View Our Latest Stock Report on AIP
Institutional Investors Weigh In On Arteris
Several institutional investors have recently made changes to their positions in the stock. PVG Asset Management Corp bought a new stake in shares of Arteris in the fourth quarter valued at approximately $151,000. PharVision Advisers LLC bought a new stake in shares of Arteris in the fourth quarter valued at approximately $173,000. Squarepoint Ops LLC bought a new stake in shares of Arteris in the fourth quarter valued at approximately $160,000. Two Sigma Advisers LP boosted its stake in shares of Arteris by 82.9% in the fourth quarter. Two Sigma Advisers LP now owns 23,600 shares of the company’s stock valued at $240,000 after buying an additional 10,700 shares during the period. Finally, Two Sigma Investments LP boosted its stake in shares of Arteris by 166.0% in the fourth quarter. Two Sigma Investments LP now owns 60,533 shares of the company’s stock valued at $617,000 after buying an additional 37,772 shares during the period. 64.36% of the stock is currently owned by institutional investors.
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Read More
- Five stocks we like better than Arteris
- What Is WallStreetBets and What Stocks Are They Targeting?
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Which Wall Street Analysts are the Most Accurate?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- 3 Small Caps With Big Return Potential
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.